Patents by Inventor Ann Thor

Ann Thor has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9539231
    Abstract: A targeted approach toward the treatment of TN breast cancer by using AMPI-109 is disclosed. AMPI-109 is a compound with remarkable “cancer-specific” characteristics. In particular, AMPI-109 demonstrates a striking targeted capability to inhibit the proliferation of TN breast cancer cells and to induce apoptosis in TN breast cancer cells. The growth inhibitory effect of AMPI-109 is independent of VDR. AMPI-109 can also be coupled with other oncolytic agents in treating a patient with TN breast cancer.
    Type: Grant
    Filed: January 17, 2014
    Date of Patent: January 10, 2017
    Assignees: The Regents of the University of Colorado, a body corporate, Trustees of Boston University
    Inventors: Hamid Gari, Jim Lambert, Scott Lucia, Rahul Ray, Ann Thor
  • Publication number: 20150202173
    Abstract: A targeted approach toward the treatment of TN breast cancer by using AMPI-109 is disclosed. AMPI-109 is a compound with remarkable “cancer-specific” characteristics. In particular, AMPI-109 demonstrates a striking targeted capability to inhibit the proliferation of TN breast cancer cells and to induce apoptosis in TN breast cancer cells. The growth inhibitory effect of AMPI-109 is independent of VDR. AMPI-109 can also be coupled with other oncolytic agents in treating a patient with TN breast cancer.
    Type: Application
    Filed: January 17, 2014
    Publication date: July 23, 2015
    Applicants: BOSTON UNIVERSITY SCHOOL OF MEDICINE, The Regents of the University of Colorado
    Inventors: Hamid Gari, Jim Lambert, Scott Lucia, Rahul Ray, Ann Thor
  • Patent number: 7588904
    Abstract: The present invention relates to compositions and methods for cancer diagnostics, prognostics and predictions, including but not limited to, cancer markers. In particular, the present invention provides perinucleolar compartments and their resident molecules as cancer markers.
    Type: Grant
    Filed: January 10, 2007
    Date of Patent: September 15, 2009
    Assignees: Northwestern University, Cold Spring Harbor Laboratory
    Inventors: Sui Huang, Rajesh V. Kamath, David Spector, Ann Thor, Chen Wang
  • Publication number: 20070117168
    Abstract: The present invention relates to compositions and methods for cancer diagnostics, prognostics and predictions, including but not limited to, cancer markers. In particular, the present invention provides perinucleolar compartments and their resident molecules as cancer markers.
    Type: Application
    Filed: January 10, 2007
    Publication date: May 24, 2007
    Inventors: Sui Huang, Rajesh Kamath, David Spector, Ann Thor, Chen Wang
  • Publication number: 20050084852
    Abstract: The present invention relates to compositions and methods for cancer diagnostics, prognostics and predictions, including but not limited to, cancer markers. In particular, the present invention provides perinucleolar compartments and their resident molecules as cancer markers.
    Type: Application
    Filed: March 31, 2003
    Publication date: April 21, 2005
    Inventors: Sui Huang, Rajesh Kamath, David Spector, Ann Thor, Chen Wang